New Rutgers Study Identifies Potential Vision Risk Linked to GLP-1 Weight Loss and Diabetes Medications
A major study led by researchers at Rutgers University has uncovered a potential, though rare, vision-related safety signal associated with the class of medications known as glucagon-like peptide-1 receptor agonists…
